Upcoding and misrepresenting clinical information constitute fraud, cost a lot, and can result in patient harm and unnecessary procedures and prescriptions.
AMA J Ethics. 2020;22(3):E221-231. doi:
10.1001/amajethics.2020.221.
Alice Wong and Dr Joseph Stramondo join us on this special episode of Ethics Talk to discuss how perspectives from the disability community can help us think more powerfully about quality of life, resource allocation, and other ethical challenges arising in pandemics. Transcript available.
When we approach art with awe and treat medicine as serious business, perhaps we’re depriving ourselves of the funniest tool in the health and wellness toolbox.
AMA J Ethics. 2020;22(7):E624-627. doi:
10.1001/amajethics.2020.624.
Jonathan Alhalel, Nicolás Francone, Sharon Post, Catherine A. O’Brian, PhD, and Melissa A. Simon, MD, MPH
Underrepresentation of individuals with limited English proficiency who speak Spanish is ongoing in phase 3 biomedical clinical trials and exacerbates health inequity.
AMA J Ethics. 2022;24(4):E319-325. doi:
10.1001/amajethics.2022.319.